Summary
Updated Aug 30, 2026
Mel Sorensen is President and CEO, Director of Galera Therapeutics, Inc. (GRTX). 2 SEC Form 4 filings on record going back to 2025, most recently on 5 August 2026. Most recent open-market trade: sold $1K of GRTX on 24 November 2025. Lifetime open-market sales: $1K.
Recent Transactions
2Every recent SEC Form 4 transaction Mel Sorensen has reported, most recent first.
Most Active Insiders Right Now
Mel Sorensen has no co-filers on record, so these are insiders with the largest open-market activity across the market in the last 90 days.
- John B. Hess - $157.37M of CVX open-market activity in the last 90 days
- Mark Barrocas - $156.00M of SN open-market activity in the last 90 days
- Richard M. Schulze - $151.14M of BBY open-market activity in the last 90 days
- PLATINUM EQUITY, LLC - $150.00M of INGM open-market activity in the last 90 days
- ADVENT INTERNATIONAL, L.P. - $147.60M of LUNR open-market activity in the last 90 days
- PAULSON CO. INC. - $146.78M of AAMI open-market activity in the last 90 days
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Mel Sorensen?
Mel Sorensen is a corporate insider, tracked as President and CEO, Director of Galera Therapeutics, Inc. (GRTX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Mel Sorensen submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Mel Sorensen been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($1K) across all tracked filings.
Where can I see all of Mel Sorensen's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Mel Sorensen and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
